Common genetic variation at BARD1 is not associated with Breast cancer risk in BRCA1 or BRCA2 mutation carriers (original) (raw)
Susan Neuhausen
2011, … Biomarkers & Prevention
visibility
…
description
12 pages
link
1 file
Sign up for access to the world's latest research.
checkGet notified about relevant papers
checkSave papers to use in your research
checkJoin the discussion with peers
checkTrack your impact
BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer
Max Chaffanet
Genes, Chromosomes and Cancer, 2010
View PDFchevron_right
Clinicopathological characteristics and BRCA1/BRCA2 pathogenic variants of patients with breast cancer
Zuhal Altıntaş
Polish Journal of Pathology, 2024
View PDFchevron_right
A new mutation of BRCA2 gene in an Italian healthy woman with familial breast cancer history
Maria Maddalena Galante
Familial Cancer, 2010
View PDFchevron_right
BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central Italy
Patrizia Di Fulvio
Human Mutation, 2003
View PDFchevron_right
Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients
Rumyana Dodova
BMC Cancer, 2015
View PDFchevron_right
A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer
Ava Kwong
Familial Cancer, 2011
View PDFchevron_right
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
Edu Velasco
Breast cancer research …, 2010
View PDFchevron_right
BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer
Daniela Turchetti
European Journal of Cancer, 2000
View PDFchevron_right
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility
Jan Kleibeuker
Journal of Medical Genetics, 2002
View PDFchevron_right
BRCA1 gene expression in relation to prognostic parameters of breast cancer
Mohamed Shehata
2011
View PDFchevron_right
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients
Theodore Anagnostopoulos
Breast Cancer Research and Treatment, 2007
View PDFchevron_right
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
Barbara Pasini
Human Molecular Genetics, 2011
View PDFchevron_right
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
diana torres
Journal of the National Cancer Institute, 2016
View PDFchevron_right
Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk
G. Rennert
PLoS Genetics, 2013
View PDFchevron_right
BRCA1 and BRCA2mutations in breast cancer patients from Venezuela
Nigmet Consigliere
Biological Research, 2012
View PDFchevron_right
Potential Excess Mortality in BRCA1/2 Mutation Carriers beyond Breast, Ovarian, Prostate, and Pancreatic Cancers, and Melanoma
Patricia Hartge
PLoS ONE, 2009
View PDFchevron_right
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
J. Gronwald
The American Journal of Human Genetics, 2003
View PDFchevron_right
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
Orland Díez
Breast Cancer Research, 2012
View PDFchevron_right
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
GUSTAVO RODRIGUEZ
2010
View PDFchevron_right
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
Mary Beattie
Breast Cancer Research, 2011
View PDFchevron_right
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Ignacio Blanco
Human Molecular Genetics, 2009
View PDFchevron_right
BRCA1 and TP53 Gene-Mutations: Family Predisposition and Radioecological Risk of Developing Breast Cancer
lina Guevara
2016
View PDFchevron_right
High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area
L. Petruzelka
Breast Cancer Research, 2005
View PDFchevron_right
Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history
Rozany Dufloth
Sao Paulo Medical Journal, 2005
View PDFchevron_right
Identification of a new complex deleterious mutation in exon 18 of the BRCA2 gene in a hereditary male/female breast cancer family
Orland Díez
Breast Cancer Research and Treatment, 2010
View PDFchevron_right
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Mary Beattie
Cancer Epidemiology Biomarkers & Prevention, 2012
View PDFchevron_right
Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil
luis amendola
Brazilian Journal of Medical and Biological Research, 2009
View PDFchevron_right
BRCA testing and management of BRCA-mutated early-stage breast cancer: a comprehensive statement by expert group from GCC region
Sharif Kullab
Frontiers in oncology, 2024
View PDFchevron_right
Breast CancerBiologyRisk assessmentCancer PreventionMedicineRisk factorsGenotypeSingle Nucleotide PolymorphismPrognosisGenetic variationRisk FactorsRisk AssessmentCancer RiskCohort StudiesBreast NeoplasmsMedical and Health Sciences